Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients

Calcineurin inhibitor–associated nephrotoxicity and other adverse events have prompted efforts to minimize/eliminate calcineurin inhibitor use in kidney transplant recipients. METHODS: This open-label, randomized, multinational study evaluated the effect of planned transition from tacrolimus to siro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transplant Direct
Asıl Yazarlar: Tedesco-Silva, Helio, Peddi, V. Ram, Sánchez-Fructuoso, Ana, Marder, Brad A., Russ, Graeme R., Diekmann, Fritz, Flynn, Alison, Hahn, Carolyn M., Li, Huihua, Tortorici, Michael A., Schulman, Seth L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2016
Konular:
Kidney Transplantation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946511/
https://ncbi.nlm.nih.gov/pubmed/27500260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000579
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller